.jpg?format=webp&width=780)
The study evaluated NI‐RADS with general neuroradiologists rather than head and neck subspecialists. The study assessed 608 scans from 464 patients. For NI‐RADS categories 1, 2, and 3, primary site recurrence rates were 5%, 29%, and 65% with an AUC of 0.765, while lymph node recurrence rates were 3%, 10%, and 80% with an AUC of 0.820. As general neuroradiologists use NI-RADS effectively separating head and neck cancers into discrete categories for predicting recurrent diseases.
Like
Save
Share